| Dr Ruth Virginia Hussey, DO | |
|
25 Town Center Blvd, Suite 102, Crestview Hills, KY 41017-2539 | |
| (859) 578-8499 | |
| Not Available |
| Full Name | Dr Ruth Virginia Hussey |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 25 Town Center Blvd, Crestview Hills, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669522215 | NPI | - | NPPES |
| HU4176861 | Other | OH | MEDICARE OH |
| 0783401 | Other | KY | MEDICARE LEGACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | K02381 (Kentucky) | Primary |
| 207R00000X | Internal Medicine | K02381 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Care Of St Elizabeth Healthcare | Edgewood, KY | Hospice |
| Hospice Of The Bluegrass, Inc Dba Bluegrass Care N | Lexington, KY | Hospice |
| Carmel Manor | Fort thomas, KY | Nursing home |
| The Pavilion At Kenton | Covington, KY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Theoria Medical | 5395098339 | 90 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
A new study provides encouraging proof of the feasibility of this project, showing that both natural infection with and vaccination against SARS-CoV-2 are associated with an increase in cross-reactive antibodies against other CoVs.
As Cedars-Sinai expands telehealth and video visits and resumes surgeries, Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at the Smidt Heart Institute, has her focus on one thing: ensuring that patients with heart disease understand it is safe to be seen, and treated, by Cedars-Sinai healthcare teams.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
A recent study reports that in the airway of patients with chronic obstructive pulmonary disease (COPD), a type of airway epithelial cell – called a goblet cell – presents a prime target for the virus and plays a vital role in promoting viral replication in this tissue.
› Verified 2 days ago
| Entity Name | Ruth V Hussey Do Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922201920 PECOS PAC ID: 5890777957 Enrollment ID: O20040602001274 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
A new study provides encouraging proof of the feasibility of this project, showing that both natural infection with and vaccination against SARS-CoV-2 are associated with an increase in cross-reactive antibodies against other CoVs.
As Cedars-Sinai expands telehealth and video visits and resumes surgeries, Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at the Smidt Heart Institute, has her focus on one thing: ensuring that patients with heart disease understand it is safe to be seen, and treated, by Cedars-Sinai healthcare teams.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
A recent study reports that in the airway of patients with chronic obstructive pulmonary disease (COPD), a type of airway epithelial cell – called a goblet cell – presents a prime target for the virus and plays a vital role in promoting viral replication in this tissue.
› Verified 2 days ago
| Entity Name | Theoria Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609362375 PECOS PAC ID: 5395098339 Enrollment ID: O20211122001624 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
A new study provides encouraging proof of the feasibility of this project, showing that both natural infection with and vaccination against SARS-CoV-2 are associated with an increase in cross-reactive antibodies against other CoVs.
As Cedars-Sinai expands telehealth and video visits and resumes surgeries, Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at the Smidt Heart Institute, has her focus on one thing: ensuring that patients with heart disease understand it is safe to be seen, and treated, by Cedars-Sinai healthcare teams.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
A recent study reports that in the airway of patients with chronic obstructive pulmonary disease (COPD), a type of airway epithelial cell – called a goblet cell – presents a prime target for the virus and plays a vital role in promoting viral replication in this tissue.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ruth Virginia Hussey, DO 25 Town Center Blvd, Suite 102, Crestview Hills, KY 41017-2539 Ph: (859) 578-8499 | Dr Ruth Virginia Hussey, DO 25 Town Center Blvd, Suite 102, Crestview Hills, KY 41017-2539 Ph: (859) 578-8499 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
A new study provides encouraging proof of the feasibility of this project, showing that both natural infection with and vaccination against SARS-CoV-2 are associated with an increase in cross-reactive antibodies against other CoVs.
As Cedars-Sinai expands telehealth and video visits and resumes surgeries, Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at the Smidt Heart Institute, has her focus on one thing: ensuring that patients with heart disease understand it is safe to be seen, and treated, by Cedars-Sinai healthcare teams.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
A recent study reports that in the airway of patients with chronic obstructive pulmonary disease (COPD), a type of airway epithelial cell – called a goblet cell – presents a prime target for the virus and plays a vital role in promoting viral replication in this tissue.
› Verified 2 days ago